23.27
前日終値:
$23.10
開ける:
$23.26
24時間の取引高:
3,568
Relative Volume:
0.45
時価総額:
$N/A
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-6.22%
1か月 パフォーマンス:
+10.82%
6か月 パフォーマンス:
-19.30%
1年 パフォーマンス:
-13.95%
Tema Oncology Etf Stock (CANC) Company Profile
CANC を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
CANC
Tema Oncology Etf
|
22.86 | 0 | 0 | 0 | 0 | 0.00 |
![]()
VTI
Vanguard Total Stock Market Etf
|
280.08 | 417.53B | 0 | 0 | 0 | 0.00 |
![]()
SPY
Spdr S P 500 Etf Trust
|
568.77 | 372.57B | 0 | 0 | 0 | 0.00 |
![]()
IVV
Ishares Core S P 500 Etf
|
571.46 | 253.41B | 0 | 0 | 0 | 0.00 |
![]()
VB
Vanguard Small Cap Etf
|
224.41 | 160.59B | 0 | 0 | 0 | 0.00 |
![]()
QQQ
Invesco Qqq Trust Series 1
|
491.43 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf (CANC) 最新ニュース
(CANC) Technical Pivots with Risk Controls - news.stocktradersdaily.com
(CANC) Investment Analysis and Advice - news.stocktradersdaily.com
(CANC) Technical Data - news.stocktradersdaily.com
Trend Tracker for (CANC) - Stock Traders Daily
How To Trade (CANC) - Stock Traders Daily
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
When (CANC) Moves Investors should Listen - Stock Traders Daily
Psychedelic ETF PSIL Is 2025's Best-Performing ETF - etf.com
(CANC) Long Term Investment Analysis - Stock Traders Daily
(CANC) Trading Report - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Short Interest Update - Defense World
Trading (CANC) With Integrated Risk Controls - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Shares Sold by Jane Street Group LLC - Defense World
Reshoring ETF Gets Boost From Trump Trade - etf.com
Long Term Trading Analysis for (CANC) - Stock Traders Daily
Tema's New VOLT ETF Sparked by AI Revolution - etf.com
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
(CANC) Investment Analysis - Stock Traders Daily
Pacer Data and Digital Revolution ETF (TRFK) Institutional Ownership 2024 - MarketBeat
5 Small-cap Biotech ETFs to Watch - Investing News Network
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - Opto RoW
9 Best Biotech ETFs for 2024 - MSN
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
The 5 Best Biotech ETFs of 2024 - etf.com
5 Best Biotech ETFs To Buy - Insider Monkey
Viking Therapeutics' weight-loss tablet shows promise in small study - ETHealthWorld
Tema ETFs: A Better Way to Invest in Life Sciences - StreetInsider
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters
12 Best Healthcare ETFs To Buy - Yahoo Finance
Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq
Inside Tema ETFs' New Oncology ETF (CANC) - Nasdaq
Royalties and cancer treatments: Thematic ETFs take new directions - Investment News
Thematic ETFs Struggle to Capture Financial Advisors’ Attention - ETF.com
Tema launches three innovative, professionally managed thematic ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies - Business Wire
Getting in on global luxury - ETF Strategy
Biotechnology ETF List - ETFdb.com
Tema Oncology Etf (CANC) 財務データ
Tema Oncology Etf (CANC) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):